
Gastroenterologist

No OPD information available
Colitis
Crohn's Disease
Hemorrhagic Proctocolitis
Ulcerative Colitis
Viral Gastroenteritis
Hypophosphatemia
Osteomalacia
Anthony R. Croft is a male healthcare provider who helps people with various digestive problems like Colitis, Crohn's Disease, and Ulcerative Colitis. He also treats conditions like Hemorrhagic Proctocolitis, Viral Gastroenteritis, Hypophosphatemia, and Osteomalacia.
Anthony R. Croft uses special skills and treatments to help patients feel better. He talks to patients in a friendly way and listens to their concerns. Patients trust him because he explains things clearly and helps them understand their health issues.
Anthony R. Croft stays updated with the latest medical knowledge and research to provide the best care for his patients. He works closely with other medical professionals to learn new things and improve his skills.
Anthony R. Croft has written a publication called "Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series." This shows that he shares his knowledge with others in the medical field.
He has also been part of a clinical trial called "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease." This trial helps find new treatments for people with Crohn's Disease.
Anthony R. Croft's work has positively impacted many patients' lives by helping them manage their digestive problems and feel better. He is respected by his colleagues for his dedication to providing excellent care and for his contributions to medical research.
In summary, Anthony R. Croft is a caring healthcare provider who uses his skills and knowledge to help people with digestive issues. He stays updated with the latest medical information, works well with other medical professionals, and has made a positive impact on his patients' lives.
Enrollment Status: Completed
Published: December 27, 2024
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
